Growth Metrics

Biohaven (BHVN) Total Non-Current Liabilities (2021 - 2026)

Biohaven has reported Total Non-Current Liabilities over the past 6 years, most recently at $332.3 million for Q1 2026.

  • Quarterly results put Total Non-Current Liabilities at $332.3 million for Q1 2026, up 199.06% from a year ago — trailing twelve months through Mar 2026 was $332.3 million (up 199.06% YoY), and the annual figure for FY2025 was $394.8 million, up 111.11%.
  • Total Non-Current Liabilities reached $332.3 million in Q1 2026 per BHVN's latest filing, down from $394.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $394.8 million in Q4 2025 and bottomed at $28.4 million in Q3 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $143.8 million (2023), compared with a mean of $161.6 million.
  • Peak annual rise in Total Non-Current Liabilities hit 218.14% in 2023, while the deepest fall reached 31.19% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $120.6 million in 2022, then plummeted by 31.19% to $83.0 million in 2023, then surged by 125.33% to $187.0 million in 2024, then surged by 111.11% to $394.8 million in 2025, then fell by 15.82% to $332.3 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for BHVN at $332.3 million in Q1 2026, $394.8 million in Q4 2025, and $158.0 million in Q3 2025.